Indication
Keratoconjunctivitis sicca
5 clinical trials
7 products
Clinical trial
A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Clinical Study to Assess the Efficacy and Safety of 5% Tavilermide Ophthalmic Solution for the Treatment of Dry EyeStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Product
TavilermideClinical trial
A Phase 4, Single-Center, Open-Label Study Evaluating the Safety of the Tyrvaya Nasal PumpStatus: Terminated, Estimated PCD: 2024-02-28
Product
TyrvayaClinical trial
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Signs and Symptoms of Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-07-27
Product
PilocarpineClinical trial
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens WearersStatus: Completed, Estimated PCD: 2024-04-05
Product
MieboClinical trial
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye DiseaseStatus: Completed, Estimated PCD: 2020-06-30